1020 related articles for article (PubMed ID: 19555518)
21. Interventional studies concerning the role of antioxidant vitamins in cardiovascular diseases: a review.
Czernichow S; Hercberg S
J Nutr Health Aging; 2001; 5(3):188-95. PubMed ID: 11458291
[TBL] [Abstract][Full Text] [Related]
22. Homocysteine, folate, and cardiovascular disease.
Ward M
Int J Vitam Nutr Res; 2001 May; 71(3):173-8. PubMed ID: 11582839
[TBL] [Abstract][Full Text] [Related]
23. Dietary antioxidant intake in patients at risk for second primary cancer.
Steward DL; Wiener F; Gleich LL; Falciglia G
Laryngoscope; 2003 Sep; 113(9):1487-93. PubMed ID: 12972921
[TBL] [Abstract][Full Text] [Related]
24. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
Alemán G; Tovar AR; Torres N
Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
[TBL] [Abstract][Full Text] [Related]
25. Vitamins and minerals 4: overview of folate and the B vitamins.
Thompson J
Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
[TBL] [Abstract][Full Text] [Related]
26. [Homocysteine. The cardiovascular risk factor of the next millennium?].
Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
[TBL] [Abstract][Full Text] [Related]
27. Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins.
Lanska DJ
Handb Clin Neurol; 2010; 95():445-76. PubMed ID: 19892133
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis.
Alam MM; Mohammad AA; Shuaib U; Wang C; Ghani U; Schwindt B; Todd KG; Shuaib A
J Cereb Blood Flow Metab; 2009 Jan; 29(1):157-65. PubMed ID: 18766198
[TBL] [Abstract][Full Text] [Related]
29. [Homocysteine--risk factor or risk indicator?].
Rafflenbeul W
MMW Fortschr Med; 2005 Nov; 147(44):28-30. PubMed ID: 16302487
[TBL] [Abstract][Full Text] [Related]
30. [Are there environmental protective factors?].
Cambou JP
Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():27-31. PubMed ID: 9833077
[TBL] [Abstract][Full Text] [Related]
31. Vitamins and stroke: the homocysteine hypothesis still in doubt.
Ntaios GC; Savopoulos CG; Chatzinikolaou AC; Kaiafa GD; Hatzitolios A
Neurologist; 2008 Jan; 14(1):2-4. PubMed ID: 18195649
[TBL] [Abstract][Full Text] [Related]
32. Ischemic stroke and hyperhomocysteinemia: truth or myth?
Terwecoren A; Steen E; Benoit D; Boon P; Hemelsoet D
Acta Neurol Belg; 2009 Sep; 109(3):181-8. PubMed ID: 19902811
[TBL] [Abstract][Full Text] [Related]
33. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
[TBL] [Abstract][Full Text] [Related]
34. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.
Van Guelpen B; Hultdin J; Johansson I; Witthöft C; Weinehall L; Eliasson M; Hallmans G; Palmqvist R; Jansson JH; Winkvist A
J Intern Med; 2009 Aug; 266(2):182-95. PubMed ID: 19298497
[TBL] [Abstract][Full Text] [Related]
35. Homocysteine and arterial thrombosis: Challenge and opportunity.
Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
Antoniades C; Antonopoulos AS; Tousoulis D; Marinou K; Stefanadis C
Eur Heart J; 2009 Jan; 30(1):6-15. PubMed ID: 19029125
[TBL] [Abstract][Full Text] [Related]
37. [Homocysteine, folic acid, group B vitamins and cardiovascular risk].
Blacher J; Czernichow S; Horrellou MH; Conad J; David P; Chadefaux-Vekemans B; Ankria A; Galan P; Hercberg S; Ducimetière P
Arch Mal Coeur Vaiss; 2005 Feb; 98(2):145-52. PubMed ID: 15787307
[TBL] [Abstract][Full Text] [Related]
38. Significance of hyperhomocysteinemia.
Herrmann W
Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
[TBL] [Abstract][Full Text] [Related]
39. Vitamin E and cardiovascular disease: observational studies.
Gaziano JM
Ann N Y Acad Sci; 2004 Dec; 1031():280-91. PubMed ID: 15753154
[TBL] [Abstract][Full Text] [Related]
40. Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?
Virdis A; Ghiadoni L; Salvetti G; Versari D; Taddei S; Salvett A
J Nephrol; 2002; 15(4):414-21. PubMed ID: 12243373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
